Shanghai-based Fosun Pharmaceutical Group, the promoter of Gland Pharma, plans to sell up to a 5% stake in the company through a block deal to raise ₹1,435 crore ($172 million). This follows a successful IPO in November 2020 and is managed by UBS, as per a BSE filing. The offer price of ₹1,750 per share represents a 4.
| Subscribe To Our Free Newsletter |
